Driving change through evidence-based research | Access to Medicine

2024 ACCESS TO MEDICINE INDEX

OUR IMPACT

News

Read the latest at the Foundation

2026 Index Methodology zeroes in on scalable actions capable of delivering lasting impact for more people

Pharma companies still not maximising their potential to reach more patients in low- and middle-income countries

Access insights

Read our analyses of critical developments in the pharmaceutical industry

Commentary: Edging closer to lenacapavir access in low- and middle-income countries

29 September 2025

Harnessing Africa’s untapped clinical trial potential

22 September 2025

Recent advancements in unlocking access to RSV prevention for children in LMICs

Diabetes Care Programme

By assessing current industry practice and engaging key players to do more, we aim to drive improvements in access to diabetes care worldwide.

Research hub

Explore our research reports and publications

Featured Key findings

Pharma companies are taking steps to address access in low-income countries, but significant gaps remain

19 November 2024

Featured Key findings

Patients in low- and middle-income countries largely left out of clinical trials, limiting access to new treatments

19 November 2024

Explore per sector

R&D-based pharma companies

We encourage them to make their products accessible.

Generic medicine manufacturers

We empower the industry to become more responsive.

Medical gas companies

We stimulate the industry to ensure availability for treatments and procedures.

Diagnostic companies

We forge partnerships to unlock the potential of diagnostics.

Vaccine manufacturers

We guide them to improve access to immunisation.

Events and engagements

SHARING OUR INSIGHTS TO HELP DRIVE CHANGE

Foundation to co-host event with Fleming Initiative on AMR

Foundation to host roundtable on generic and biosimilar producers’ potential to improve access to medicine in Africa

Steffi Van Uytfanghe to speak at webinar on medical oxygen access barriers in LMICs

21 November 2025

Featured Panel discussion

Jayasree K. Iyer to attend JP Morgan 2026 Healthcare Conference in San Francisco

14 January 2026

Media coverage

Read more about our coverage in global media

Op-ed: Improving access to innovative medicines in Africa starts with clinical trials

Op-ed: The need to strengthen the US Food and Drug Administration: US cuts threaten health care at home and abroad